局部区域非小细胞肺癌放疗后生存与FDG-PET中心光子缺失的关系
本研究基于TROG 99-05前瞻性试验数据,评估治疗前FDG-PET显示原发肿瘤中心光子缺失与接受根治性放疗的局部区域非小细胞肺癌患者生存的关系。单因素及调整性别、体能状态和淋巴结状态后,光子缺失均未与更差生存显著相关(HR=1.20,95%CI 0.78-1.87,p=0.4),但与更大肿瘤体积和体重下降显著相关。
要点
- 中心光子缺失与放疗后生存无显著关联(HR=1.20,95%CI 0.78-1.87,p=0.4)。
- 光子缺失与更大肿瘤体积和体重下降显著相关。
- 两位观察者判断光子缺失的一致性为90%(Kappa=0.822,p<0.001)。
核心结论
- 本研究未能证明接受放疗的非小细胞肺癌患者中,原发肿瘤中心光子缺失与显著更差的生存相关。
研究设计与样本
- 数据来自前瞻性试验TROG 99-05,该试验研究接受根治性放疗的局部区域非小细胞肺癌患者原发肿瘤体积的预后意义。
- 研究人群为其中治疗前接受FDG-PET扫描的患者亚组,共172例可评估患者。
- 由两位观察者使用视觉评分系统评估原发肿瘤中心光子缺失,并在调整其他预后因素后分析其与生存的关系。
主要发现
- 两位观察者对光子缺失存在与否的判断在90%的病例中一致(Kappa=0.822,p<0.001)。
- 单因素分析中光子缺失未与更差生存相关。
- 调整性别、体能状态和淋巴结状态后,光子缺失与生存的关联无统计学意义(HR=1.20,95%CI 0.78-1.87,p=0.4)。
- 光子缺失与更大肿瘤体积和体重下降显著相关。
临床怎么用
- 对于接受根治性放疗的局部区域非小细胞肺癌患者,治疗前FDG-PET显示的中心光子缺失不应单独作为判断预后更差的依据。
- 中心光子缺失与更大肿瘤体积和体重下降相关,提示此类患者可能肿瘤负荷较大或营养状态较差。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Primary non-small cell lung cancer cavitation and central photopenia, detected by radiology and FDG-PET scanning respectively, are thought to be the result of tumor necrosis. Such regions may contain hypoxic but viable carcinoma cells which may be relatively radioresistant compared with fully oxygenated regions. We hypothesized that photopenic tumors treated with radiotherapy with or without chemotherapy would be associated with worse survival compared with tumors not showing central photopenia. PATIENTS AND METHODS: The data were from a prospective trial (TROG 99-05) investigating the prognostic significance of primary tumor volume in patients receiving radical radiotherapy for locoregional non-small cell lung cancer (NSCLC). A subset of patients who had a pre-treatment FDG-PET scan formed the study population. The scans were evaluated by two observers for central photopenia in the primary tumor using a visual scoring system. The relationship of photopenia with survival was determined after adjusting for other prognostic factors. RESULTS: There were 172 eligible patients. The two observers agreed on the presence of photopenia in 90% of cases (Kappa=0.822, p<0.001). Seventy-three patients were scored as having photopenia. Photopenia was not associated with worse survival, either on univariate analysis, or after adjusting for sex, performance status and nodal status (HR=1.20, 95% CI 0.78-1.87, p=0.4) Photopenia was however significantly associated with larger tumor volume and weight loss. CONCLUSIONS: This study failed to demonstrate a significantly worse survival associated with central photopenia in patients treated with radiotherapy for NSCLC.
引用
- Ashley Cox R, Akhurst T, Bressel M, et al. Survival and central photopenia detected by fluorine-18 fluoro-deoxy-glucose positron emission tomography (FDG-PET) in patients with locoregional non-small cell lung cancer treated with radiotherapy. Radiother Oncol. 2017. PMID: 28662870. doi:10.1016/j.radonc.2017.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。